title-pule-iconUTEGCILTM

Tegafur 100mg and Uracil 224mg capsules

Sayre Therapeutics offers clinicians a convenient and effective oral formulation of Tegafur ( pro-drug of 5-FU) with Uracil for the management of metastatic colorectal cancer.

  • Indication: TEGAFUR 100mg + URACIL 224mg capsules is indicated for the first line treatment of metastatic colorectal cancer with calcium folinate.
  • Formulation: TEGAFUR 100mg + URACIL 224mg capsules are supplied as 1× 10’s Blister pack.
  • Utegcil® is:
    • Has comparable clinical efficacy to bolus 5-FU/LV in patients with metastatic colorectal cancer.
    • When administered with Leucovorin, provides better safety profile compared with 5-FU/LV.
    • More than 80% of patients preferred oral Tegafur/Uracil to I.V. bolus 5-FU.

(One liner at the bottom like that for other products)

-Convenience coupled with uncompromised clinical outcome

celstemX by sayre therapeutics

For more information regarding UTEGCILTM, please contact your local sales representative or email us at info@sayretherapeutics.com